Genetic testing for cancer predisposition syndromes in pediatric cancer patients: current practices and recommendations - a systematic review
References
- Wu Y, Deng Y, Wei B, Xiang D, Hu J, Zhao P, et al. Global, regional, and national childhood cancer burden, 1990-2019: an analysis based on the Global Burden of Disease Study 2019. J Adv Res 2022; 40: 233-47. doi: 10.1016/j.jare.2022.06.001
- Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. Cell 2018; 173: 355-70.e14. doi: 10.1016/j.cell.2018.03.039
- Scollon S, Anglin AK, Thomas M, Turner JT, Wolfe Schneider K. A comprehensive review of pediatric tumors and associated cancer predisposition syndromes. J Genet Couns 2017; 26: 387-434. doi: 10.1007/s10897-017-0077-8
- Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 2015; 373: 2336-46. doi: 10.1056/NEJMoa1508054
- Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, et al. The landscape of genomic alterations across childhood cancers. Nature 2018; 555: 321-7. doi: 10.1038/nature25480
- Wong M, Mayoh C, Lau LMS, Khuong-Quang DA, Pinese M, Kumar A, et al. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nat Med 2020; 26: 1742-53. doi: 10.1038/s41591-020-1072-4
- Byrjalsen A, Hansen TVO, Stoltze UK, Mehrjouy MM, Barnkob NM, Hjalgrim LL, et al. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes. PLoS Genet 2020; 16: e1009231. doi: 10.1371/journal.pgen.1009231
- Wagener R, Taeubner J, Walter C, Yasin L, Alzoubi D, Bartenhagen C, et al. Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer. Eur J Hum Genet EJHG 2021; 29: 1301-11. doi: 10.1038/s41431-021-00878-x
- Gargallo P, Oltra S, Yáñez Y, Juan-Ribelles A, Calabria I, Segura V, et al. Germline predisposition to pediatric cancer, from next generation sequencing to medical care. Cancers 2021; 13: 5339. doi: 10.3390/cancers13215339
- Fiala EM, Jayakumaran G, Mauguen A, Kennedy JA, Bouvier N, Kemel Y, et al. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nat Cancer 2021; 2: 357-65. doi: 10.1038/s43018-021-00172-1
- Newman S, Nakitandwe J, Kesserwan CA, Azzato EM, Wheeler DA, Rusch M, et al. Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing. Cancer Discov 2021; 11: 3008-27. doi: 10.1158/2159-8290.CD-20-1631
- Diets IJ, Waanders E, Ligtenberg MJ, van Bladel DAG, Kamping EJ, Hoogerbrugge PM, et al. High yield of pathogenic germline mutations causative or likely causative of the cancer phenotype in selected children with cancer. Clin Cancer Res 2018; 24: 1594-603. doi: 10.1158/1078-0432.CCR-17-1725
- Jongmans MCJ, Loeffen JLCM, Waanders E, Hoogerbrugge PM, Ligtenberg MJL, Kuiper RP, et al. Recognition of genetic predisposition in pediatric cancer patients: an easy-to-use selection tool. Eur J Med Genet 2016; Special Issue: Acute lymphoblastic leukemia prone syndromes 59: 116-25. doi: 10.1016/j.ejmg.2016.01.008
- Kesserwan C, Friedman Ross L, Bradbury AR, Nichols KE. The advantages and challenges of testing children for heritable predisposition to cancer. Am Soc Clin Oncol Educ Book 2016; 35: 251-69. doi: 10.1200/EDBK_160621
- Grill J, Dhermain F, Habrand JL. Risks of radiation therapy in patients with neurofibromatosis. Int J Radiat Oncol Biol Phys 2009; 75: 632. doi: 10.1016/j.ijrobp.2009.03.076
- Hachmeriyan M, Levkova M, Yahya D, Stoyanova M, Dimitrova E. Ethical and psychosocial issues associated with genetic testing for hereditary tumor predisposition syndromes. Healthcare (Basel) 2025; 13:880. doi: 10.3390/healthcare13080880
- Droin-Mollard M, de Montgolfier S, Gimenez-Roqueplo AP, Flahault C, Petit A, Bourdeaut F, et al. Psychological and ethical issues raised by genomic in paediatric care pathway, a qualitative analysis with parents and childhood cancer patients. Eur J Hum Genet EJHG 2024; 32: 1446–55. doi: 10.1038/s41431-024-01653-4
- Carver T, Hartley S, Lee A, Cunningham AP, Archer S, Babb de Villiers C, et al. CanRisk tool-a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiol Biomark Prev 2021; 30: 469-73. doi: 10.1158/1055-9965.EPI-20-1319
- Knapke S, Nagarajan R, Correll J, Kent D, Burns K. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatr Blood Cancer 2012; 58: 85-9. doi: 10.1002/pbc.23283
- Merks JHM, Caron HN, Hennekam RCM. High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A. 2005;134A: 132-43. doi: 10.1002/ajmg.a.30603
- Khater F, Vairy S, Langlois S, Dumoucel S, Sontag T, St-Onge P, et al. Molecular profiling of hard-to-treat childhood and adolescent cancers. JAMA Netw Open 2019; 2: e192906. doi: 10.1001/jamanetworkopen.2019.2906
- Goudie C, Coltin H, Witkowski L, Mourad S, Malkin D, Foulkes WD. The McGill interactive pediatric oncogenetic guidelines: an approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation. Pediatr Blood Cancer 2017; 64: doi: 10.1002/pbc.26441
- Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, et al. Childhood cancer predisposition syndromes - a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 2017; 173: 1017-37. doi: 10.1002/ajmg.a.38142
- Druker H, Zelley K, McGee RB, Scollon SR, Kohlmann WK, Schneider KA, et al. Genetic counselor recommendations for cancer predisposition evaluation and surveillance in the pediatric oncology patient. Clin Cancer Res 2017; 23: e91-7. doi: 10.1158/1078-0432.CCR-17-0834
- Harttrampf AC, Lacroix L, Deloger M, Deschamps F, Puget S, Auger N, et al. Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial. Clin Cancer Res 2017; 23: 6101-12. doi: 10.1158/1078-0432.CCR-17-0381
- Worst BC, van Tilburg CM, Balasubramanian GP, Fiesel P, Witt R, Freitag A, et al. Next-generation personalised medicine for high-risk paediatric cancer patients - the INFORM pilot study. Eur J Cancer 2016; 65: 91-101. doi: 10.1016/j.ejca.2016.06.009
- Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 2018; 19: 785-98. doi: 10.1016/S1470-2045(18)30242-0
- Wagener R, Taeubner J, Walter C, Yasin L, Alzoubi D, Bartenhagen C, et al. Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer. Eur J Hum Genet 2021; 29: 1301-11. doi: 10.1038/s41431-021-00878-x
- Li H, Sisoudiya SD, Martin-Giacalone BA, Khayat MM, Dugan-Perez S, Marquez-Do DA, et al. Germline cancer predisposition variants in pediatric rhabdomyosarcoma: a report from the Children’s Oncology Group. J Natl Cancer Inst 2021; 113: 875-83. doi: 10.1093/jnci/djaa204
- Wang Z, Wilson CL, Easton J, Thrasher A, Mulder H, Liu Q, et al. Genetic risk for subsequent neoplasms among long-term survivors of childhood cancer. J Clin Oncol 2018; 36: 2078-87. doi: 10.1200/JCO.2018.77.8589
- Friedrich UA, Bienias M, Zinke C, Prazenicova M, Lohse J, Jahn A, et al. A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children. Genet Med 2023; 25: 100875. doi: 10.1016/j.gim.2023.100875
- Wilson CL, Wang Z, Liu Q, Ehrhardt MJ, Mostafavi R, Easton J, et al. Estimated number of adult survivors of childhood cancer in United States with cancerpredisposing germline variants. Pediatr Blood Cancer 2020; 67: e28047. doi: 10.1002/pbc.28047
- Byrjalsen A, Hansen TVO, Stoltze UK, Mehrjouy MM, Barnkob NM, Hjalgrim LL, et al. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes. PLoS Genet 2020; 16: e1009231. doi: 10.1371/journal.pgen.1009231
- van der Tuin K, Ruano D, Knijnenburg J, van der Luijt RB, Morreau H, Links TP, et al. Clinically relevant germline variants in children with nonmedullary thyroid cancer. J Clin Endocrinol Metab 2024; 109: e2214-21. doi: 10.1210/clinem/dgae107
- Kratz CP, Smirnov D, Autry R, Jäger N, Waszak SM, Großhennig A, et al. Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer. J Natl Cancer Inst 2022; 114: 1523-32. doi: 10.1093/jnci/djac151
- Rana HQ, Gelman R, LaDuca H, McFarland R, Dalton E, Thompson J, et al. Differences in TP53 mutation carrier phenotypes emerge from panel-based testing. J Natl Cancer Inst 2018; 110: 863-70. doi: 10.1093/jnci/djy001
- Daugs K, Brandes D, Yasin L, Anwar A, Alam J, Prasad Y, et al. Germline variants observed in pediatric cancer patients related to hereditary breast and ovarian cancer in adults. Int J Cancer 2025; 157: 2447-54. doi: 10.1002/ijc.70097
- Zhou L, Singh P, Crossman D, Richman J, Trainor P, Cheng C, et al. Germline pathogenic/likely pathogenic mutations and subsequent neoplasms among childhood cancer survivors: a report from the children’s oncology group ALTE03N1 study. J Clin Oncol 2025; 43: 3011-20. doi: 10.1200/JCO-25-00542
- Sylvester DE, Chen Y, Jamieson RV, Dalla-Pozza L, Byrne JA. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature. J Med Genet 2018; 55: 785-93. doi: 10.1136/jmedgenet-2018-105488
- Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, et al. Revisiting Li-Fraumeni syndrome From TP53 mutation carriers. J Clin Oncol 2015; 33: 2345-52. doi: 10.1200/JC0.2014.59.5728
- Sylvester DE, Chen Y, Grima N, Saletta F, Padhye B, Bennetts B, et al. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer. Genes Chromosomes Cancer 2022; 61: 81-93. doi: 10.1002/gcc.23006
- Bakhuizen JJ, Bourdeaut F, Wadt KAW, Kratz CP, Jongmans MCJ, Waespe N. Genetic testing for childhood cancer predisposition syndromes: controversies and recommendations from the SIOPE Host Genome Working Group meeting 2022. EJC Paediatr Oncol 2024; 4: 100176. doi: 10.1016/j.ejcped.2024.100176
- Cancer Institute NSW. Paediatric cancers or tumours – when a genetic assessment is indicated. ID: 3739 v8. eviQ [Internet]. [cited 2025 Dec 01]. Available at: https://www.eviq.org.au/cancer-genetics/referral-guidelines/3739-paediatric-cancers-or-tumours-when-a-geneti#reference-30ae002c-ead9-45eb-a854-7e866d7cc22d
- Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, et al. Childhood cancer predisposition syndromes - a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 2017; 173: 1017-37. doi: 10.1002/ajmg.a.38142
- Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, et al. Performance of the McGill interactive pediatric oncogenetic guidelines for identifying cancer predisposition syndromes. JAMA Oncol 2021; 7: 1806. doi: 10.1001/jamaoncol.2021.4536
- Karolinska University Hospital. Whole genome sequencing becomes routine for pediatric cancer at Karolinska [Internet]. 2024 [cited 2025 Dec 15]. Available at: https://www.karolinskahospital.com/news/whole-genome-sequencing-becomes-clinical-routine-for-all-cases-of-pediatric-cancer-at-karolinska-university-hospital/
- European Partnership for Personalised Medicine. EP PerMed. Childhood cancer in Sweden [Internet]. [cited 2025 Dec 13]. Available at: https://www.eppermed.eu/publications-resources/ep-permed-publications/best-practices/childhood-cancer-in-sweden/
- Jongmans MCJ, Loeffen JLCM, Waanders E, Hoogerbrugge PM, Ligtenberg MJL, Kuiper RP, et al. Recognition of genetic predisposition in pediatric cancer patients: an easy-to-use selection tool. Eur J Med Genet 2016; 59: 116-25. doi: 10.1016/j.ejmg.2016.01.008
- Borja NA, Silva-Smith R, Calfa C, Sussman DA, Tekin M. Triple primary cancers: an analysis of genetic and environmental factors. Cancer Prev Res 2024; 17: 209-15. doi: 10.1158/1940-6207.CAPR-23-0395
- Roganovic J. Genetic predisposition to childhood cancer. World J Clin Pediatr 2024; 13: 95010. doi: 10.5409/wjcp.v13.i3.95010
- Dixon SB, Liu Q, Chow EJ, Oeffinger KC, Nathan PC, Howell RM, et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet 2023; 401: 1447-57. doi: 10.1016/S0140-6736(22)02471-0
- Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 2016; 374: 833-42. doi: 10.1056/NEJMoa1510795
- Bhatia S, Tonorezos ES, Landier W. Clinical care for people who survive childhood cancer: a review. JAMA 2023; 330: 1175-86. doi: 10.1001/jama.2023.16875
- Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, et al. Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015. JAMA 2017; 317: 814-24. doi: 10.1001/jama.2017.0693
- Turcotte LM, Liu Q, Yasui Y, Henderson TO, Gibson TM, Leisenring W, et al. Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort. J Clin Oncol 2019; 37: 3310-9. doi: 10.1200/JCO.19.00129
- Rahman N. Realizing the promise of cancer predisposition genes. Nature 2014; 505: 302-8. doi: 10.1038/nature12981
- Wang Z, Wilson CL, Easton J, Thrasher A, Mulder H, Liu Q, et al. Genetic risk for subsequent neoplasms among long-term survivors of childhood cancer. J Clin Oncol 2018; 36: 2078-87. doi: 10.1200/JCO.2018.77.8589
- Cesen Mazic M, Reulen RC, Jazbec J, Zadravec Zaletel L. Trends in treatment of childhood cancer and subsequent primary neoplasm risk. Radiol Oncol 2022; 56: 380-9. doi: 10.2478/raon-2022-0027
- Nakano Y, Rabinowicz R, Malkin D. Genetic predisposition to cancers in children and adolescents. Curr Opin Pediatr 2023; 35: 55. doi: 10.1097/MOP.0000000000001197
- Plon SE, Nathanson K. Inherited susceptibility fo r pediatric cancer. Cancer J 2005; 11: 255-67. doi: 10.1097/00130404-200507000-00002
- Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL, Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med 2015; 17: 70-87. doi: 10.1038/gim.2014.147
- Claussnitzer M, Cho JH, Collins R, Cox NJ, Dermitzakis ET, Hurles ME, et al. A brief history of human disease genetics. Nature 2020; 577: 179-89. doi: 10.1038/s41586-019-1879-7
- Tesi B, Robinson KL, Abel F, Díaz de Ståhl T, Orrsjö S, Poluha A, et al. Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors-a nationwide, prospective Swedish study. Lancet Reg Health Eur 2024; 39: 100881. doi: 10.1016/j.lanepe.2024.100881
- Kratz CP, Jongmans MC, Cavé H, Wimmer K, Behjati S, Guerrini-Rousseau L, et al. Predisposition to cancer in children and adolescents. Lancet Child Adolesc Health 2021; 5: 142-54. doi: 10.1016/S2352-4642(20)30275-3 PubMed PMID: 33484663.
- Ripperger T, Evans DG, Malkin D, Kratz CP. Choose and stay on one out of two paths: Distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer. Fam Cancer 2021; 20: 289-91. doi: 10.1007/s10689-021-00228-2
- van Engelen K, Barrera M, Wasserman JD, Armel SR, Chitayat D, Druker H, et al. Tumor surveillance for children and adolescents with cancer predisposition syndromes: the psychosocial impact reported by adolescents and caregivers. Pediatr Blood Cancer 2021; 68: e29021. doi: 10.1002/pbc.29021
- Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2015; 33: 3660-7. doi: 10.1200/JCO.2015.63.0996
- Malkin D. Surveillance for children at genetic risk for cancer: are we ready? Pediatr Blood Cancer 2014; 61: 1337-8. doi: 10.1002/pbc.25061
- Wakefield CE, Hanlon LV, Tucker KM, Patenaude AF, Signorelli C, McLoone JK, et al. The psychological impact of genetic information on children: a systematic review. Genet Med 2016; 18: 755-62. doi: 10.1038/gim.2015.181
- Foulkes WD, Buu PN, Filiatrault D, Leclerc JM, Narod SA. Excess of congenital abnormalities in French-Canadian children with neuroblastoma: a case series study from Montréal. Med Pediatr Oncol 1997; 29: 272-9. doi: 10.1002/(sici)1096-911x(199710)29:4<;272::aid-mpo7>3.0.co;2-j
- Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 1997; 60: 474-85. PMID: 9042906
- Hanington L, Walker L, Wilson S. Paediatric cancer predisposition syndromes in the genomic age. Paediatr Child Health 2022; 32: 184-90. doi: 10.1016/j.paed.2022.02.003
Language: English
Submitted on: Mar 18, 2026
Accepted on: May 17, 2026
Published on: Jul 6, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Anja Urbas, Polona Usaj, Bostjan Seruga, Lorna Zadravec Zaletel, Mateja Krajc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.